IBDEI267 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36415,1,1,0)
 ;;=1^J9999
 ;;^UTILITY(U,$J,358.3,36415,1,3,0)
 ;;=3^Oxaliplatin Inj 1mg
 ;;^UTILITY(U,$J,358.3,36416,0)
 ;;=96376^^167^1840^90^^^^1
 ;;^UTILITY(U,$J,358.3,36416,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36416,1,1,0)
 ;;=1^96376
 ;;^UTILITY(U,$J,358.3,36416,1,3,0)
 ;;=3^Tx/Pro/Dx Inj Same Drug Add-on
 ;;^UTILITY(U,$J,358.3,36417,0)
 ;;=J9245^^167^1840^61^^^^1
 ;;^UTILITY(U,$J,358.3,36417,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36417,1,1,0)
 ;;=1^J9245
 ;;^UTILITY(U,$J,358.3,36417,1,3,0)
 ;;=3^Melphalan Hydrochl Inj 50mg
 ;;^UTILITY(U,$J,358.3,36418,0)
 ;;=C9257^^167^1840^11^^^^1
 ;;^UTILITY(U,$J,358.3,36418,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36418,1,1,0)
 ;;=1^C9257
 ;;^UTILITY(U,$J,358.3,36418,1,3,0)
 ;;=3^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,36419,0)
 ;;=Q2049^^167^1840^35^^^^1
 ;;^UTILITY(U,$J,358.3,36419,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36419,1,1,0)
 ;;=1^Q2049
 ;;^UTILITY(U,$J,358.3,36419,1,3,0)
 ;;=3^Doxorubicin HCl,Liposomal Inj 10mg
 ;;^UTILITY(U,$J,358.3,36420,0)
 ;;=J3489^^167^1840^93^^^^1
 ;;^UTILITY(U,$J,358.3,36420,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36420,1,1,0)
 ;;=1^J3489
 ;;^UTILITY(U,$J,358.3,36420,1,3,0)
 ;;=3^Zoledronic Acid Inj 1mg
 ;;^UTILITY(U,$J,358.3,36421,0)
 ;;=J9219^^167^1840^56^^^^1
 ;;^UTILITY(U,$J,358.3,36421,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36421,1,1,0)
 ;;=1^J9219
 ;;^UTILITY(U,$J,358.3,36421,1,3,0)
 ;;=3^Lupron Acetate Implant 65mg
 ;;^UTILITY(U,$J,358.3,36422,0)
 ;;=J0641^^167^1840^55^^^^1
 ;;^UTILITY(U,$J,358.3,36422,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36422,1,1,0)
 ;;=1^J0641
 ;;^UTILITY(U,$J,358.3,36422,1,3,0)
 ;;=3^Levoleucovorin Calcium Inj 0.5mg
 ;;^UTILITY(U,$J,358.3,36423,0)
 ;;=J0894^^167^1840^29^^^^1
 ;;^UTILITY(U,$J,358.3,36423,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36423,1,1,0)
 ;;=1^J0894
 ;;^UTILITY(U,$J,358.3,36423,1,3,0)
 ;;=3^Decitabine Inj 1mg
 ;;^UTILITY(U,$J,358.3,36424,0)
 ;;=J0897^^167^1840^30^^^^1
 ;;^UTILITY(U,$J,358.3,36424,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36424,1,1,0)
 ;;=1^J0897
 ;;^UTILITY(U,$J,358.3,36424,1,3,0)
 ;;=3^Denosumab Inj 1mg
 ;;^UTILITY(U,$J,358.3,36425,0)
 ;;=J1453^^167^1840^43^^^^1
 ;;^UTILITY(U,$J,358.3,36425,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36425,1,1,0)
 ;;=1^J1453
 ;;^UTILITY(U,$J,358.3,36425,1,3,0)
 ;;=3^Fosaprepitant Inj 1mg
 ;;^UTILITY(U,$J,358.3,36426,0)
 ;;=J1710^^167^1840^47^^^^1
 ;;^UTILITY(U,$J,358.3,36426,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36426,1,1,0)
 ;;=1^J1710
 ;;^UTILITY(U,$J,358.3,36426,1,3,0)
 ;;=3^Hydrocortisone Sodium Phos Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,36427,0)
 ;;=J2150^^167^1840^59^^^^1
 ;;^UTILITY(U,$J,358.3,36427,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36427,1,1,0)
 ;;=1^J2150
 ;;^UTILITY(U,$J,358.3,36427,1,3,0)
 ;;=3^Mannitol 25% in 50 ml
 ;;^UTILITY(U,$J,358.3,36428,0)
 ;;=J2354^^167^1840^71^^^^1
 ;;^UTILITY(U,$J,358.3,36428,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36428,1,1,0)
 ;;=1^J2354
 ;;^UTILITY(U,$J,358.3,36428,1,3,0)
 ;;=3^Octreotide IV 1mg
 ;;^UTILITY(U,$J,358.3,36429,0)
 ;;=J2997^^167^1840^5^^^^1
 ;;^UTILITY(U,$J,358.3,36429,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36429,1,1,0)
 ;;=1^J2997
 ;;^UTILITY(U,$J,358.3,36429,1,3,0)
 ;;=3^Alteplase Recombinant 1mg
 ;;^UTILITY(U,$J,358.3,36430,0)
 ;;=J3262^^167^1840^86^^^^1
 ;;^UTILITY(U,$J,358.3,36430,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36430,1,1,0)
 ;;=1^J3262
 ;;^UTILITY(U,$J,358.3,36430,1,3,0)
 ;;=3^Tacilizumab Inj 1mg
 ;;^UTILITY(U,$J,358.3,36431,0)
 ;;=J9033^^167^1840^10^^^^1
